PCI Biotech Holding ASA has a quick ratio of 2.94. It generally indicates good short-term financial strength.
The historical rank and industry rank for PCI Biotech Holding ASA's Quick Ratio or its related term are showing as below:
OSL:PCIB'
s Quick Ratio Range Over the Past 10 Years
Min: 2.4 Med: 7.73 Max: 21.01
Current: 2.94
During the past 13 years, PCI Biotech Holding ASA's highest Quick Ratio was 21.01. The lowest was 2.40. And the median was 7.73.
OSL:PCIB's Quick Ratio is not ranked
in the Biotechnology industry.
Industry Median: 3.6
vs OSL:PCIB: 2.94
PCI Biotech Holding ASA (OSL:PCIB) Quick Ratio Explanation
The quick ratio is more conservative than the Current Ratio because it excludes inventories from current assets. The ratio derives its name presumably from the fact that assets such as cash and marketable securities are quick sources of cash. Inventories generally take time to be converted into cash, and if they have to be sold quickly, the company may have to accept a lower price than book value of these inventories. As a result, they are justifiably excluded from assets that are ready sources of immediate cash.
In general, low or decreasing quick ratios generally suggest that a company is over-leveraged, struggling to maintain or grow sales, paying bills too quickly or collecting receivables too slowly. On the other hand, a high or increasing quick ratio generally indicates that a company is experiencing solid top-line growth, quickly converting receivables into cash, and easily able to cover its financial obligations. Such companies often have faster inventory turnover and cash conversion cycles.
The higher the quick ratio, the better the company's liquidity position.
PCI Biotech Holding ASA Quick Ratio Related Terms
PCI Biotech Holding ASA Quick Ratio Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
OSL:PCIB vs VRTX, REGN, ALNY: Quick Ratio Comparison
For the Biotechnology subindustry, PCI Biotech Holding ASA's Quick Ratio, along with its competitors' market caps and Quick Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
PCI Biotech Holding ASA Quick Ratio vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, PCI Biotech Holding ASA's Quick Ratio distribution charts can be found below:
* The bar in red indicates where PCI Biotech Holding ASA's Quick Ratio falls into.
The quick ratio measures a company's ability to meet its short-term obligations with its most liquid assets. For this reason, the ratio excludes inventories from current assets.
PCI Biotech Holding ASA's Quick Ratio for the fiscal year that ended in Dec. 2024 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
PCI Biotech Holding ASA (OSL:PCIB) has a Quick Ratio of 2.94 as of Jun. 2025. Quick ratio is the ratio of current assets less inventory to current liabilities. View historical data on PCI Biotech Holding ASA and its competitors. This is 62% below median its historical median of 7.73. Over the past decade, PCI Biotech Holding ASA's Quick Ratio has ranged from 2.40 to 21.01.
Is PCI Biotech Holding ASA's Quick Ratio too high?
PCI Biotech Holding ASA's current Quick Ratio of 2.94 is 62% below median its 10-year median of 7.73. Over the past 10 years, this metric has ranged from a low of 2.40 to a high of 21.01. The Biotechnology industry median Quick Ratio is 3.60. PCI Biotech Holding ASA's value of 2.94 is 18.3% below this industry median. Overall, PCI Biotech Holding ASA has a GF Score™ of 6/100, reflecting its overall financial health beyond just this single metric.
How does PCI Biotech Holding ASA's Quick Ratio compare to VRTX and REGN?
PCI Biotech Holding ASA's Quick Ratio of 2.94 can be compared against companies in the Biotechnology industry. The industry median Quick Ratio is 3.60. PCI Biotech Holding ASA's value of 2.94 is 18.3% below this benchmark. Historically, PCI Biotech Holding ASA's own Quick Ratio has ranged from 2.40 to 21.01 over the past decade. While the company's 10-year median is 7.73 vs. the industry median of 3.60, PCI Biotech Holding ASA has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Quick Ratio for a Biotechnology company?
The median Quick Ratio among Biotechnology companies is 3.60, based on 1,411 companies in the industry. Companies in the top quartile (top 25%) have a Quick Ratio significantly above this median, while those in the bottom quartile fall well below. However, Quick Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. PCI Biotech Holding ASA's current Quick Ratio of 2.94 is 18.3% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Quick Ratio mean?
A high Quick Ratio can signal that a stock is expensive relative to its fundamentals. Quick ratio is the ratio of current assets less inventory to current liabilities. View historical data on PCI Biotech Holding ASA and its competitors. For the Biotechnology industry, the median Quick Ratio is 3.60 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. PCI Biotech Holding ASA's current Quick Ratio is 2.94, which is 62% below median its own 10-year median of 7.73. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PCI Biotech Holding ASA stock overvalued right now?
PCI Biotech Holding ASA (OSL:PCIB) has a current Quick Ratio of 2.94. The current Quick Ratio is 2.94, which is 62% below median its 10-year median of 7.73 and 18.3% below the Biotechnology industry median of 3.60. PCI Biotech Holding ASA's overall GF Score™ is 6/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Quick Ratio calculated?
Quick Ratio is calculated from a company's financial statements. For PCI Biotech Holding ASA (OSL:PCIB), the current Quick Ratio is 2.94 as of Jun. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
PCI Biotech Holding ASA is a biopharmaceutical company focused on developing and commercializing cancer therapies using its photochemical internalization (PCI) technology platform. The PCI technology utilizes light to trigger the release of compounds from within cellular compartments. The company applies PCI to three different approaches for cancer treatment: fimaCHEM: Enhancing chemotherapeutic drugs for localized cancer treatment. fimaVACC: Inducing T-cell responses for therapeutic cancer vaccination. fimaNAc: Delivering nucleic acid therapeutics. The key product candidate is fimaporfin (Amphinex), a photosensitizer that can unlock intracellular compartments where active compounds are trapped. The company's sole operating segment is research and development.
6GF Score
Get the complete analysis for OSL:PCIB
Quick Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
OSL:PCIB has been successfully added to your 
